These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 31158720)

  • 21. Dorsolateral Prefrontal Cortex and Subcallosal Cingulate Connectivity Show Preferential Antidepressant Response in Major Depressive Disorder.
    Chin Fatt CR; Cooper C; Jha MK; Aslan S; Grannemann B; Kurian B; Greer TL; Fava M; Weissman M; McGrath PJ; Parsey RV; Etkin A; Phillips ML; Trivedi MH
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Jan; 6(1):20-28. PubMed ID: 32921587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spotlight on sertraline in the management of major depressive disorder in elderly patients.
    Muijsers RB; Plosker GL; Noble S
    CNS Drugs; 2002; 16(11):789-94. PubMed ID: 12383038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotonin transporter binding as a possible predictor of one-year remission in major depressive disorder.
    Miller JM; Oquendo MA; Ogden RT; Mann JJ; Parsey RV
    J Psychiatr Res; 2008 Oct; 42(14):1137-44. PubMed ID: 18331740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pretreatment Rostral Anterior Cingulate Cortex Connectivity With Salience Network Predicts Depression Recovery: Findings From the EMBARC Randomized Clinical Trial.
    Whitton AE; Webb CA; Dillon DG; Kayser J; Rutherford A; Goer F; Fava M; McGrath P; Weissman M; Parsey R; Adams P; Trombello JM; Cooper C; Deldin P; Oquendo MA; McInnis MG; Carmody T; Bruder G; Trivedi MH; Pizzagalli DA
    Biol Psychiatry; 2019 May; 85(10):872-880. PubMed ID: 30718038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resolution of sleepiness and fatigue: a comparison of bupropion and selective serotonin reuptake inhibitors in subjects with major depressive disorder achieving remission at doses approved in the European Union.
    Cooper JA; Tucker VL; Papakostas GI
    J Psychopharmacol; 2014 Feb; 28(2):118-24. PubMed ID: 24352716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serotonin 1A receptor density measured by F18-Mefway PET/CT in mesiotemporal cortex and raphe does not discriminate therapeutic response in patients with major depressive episode.
    Barth M; Dunzinger A; Wimmer I; Winkler J; Rittmannsberger H; Nader M; Pichler R
    Q J Nucl Med Mol Imaging; 2020 Jun; 64(2):203-210. PubMed ID: 29916219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amygdala biomarkers of treatment response in major depressive disorder: An fMRI systematic review of SSRI antidepressants.
    Tassone VK; Gholamali Nezhad F; Demchenko I; Rueda A; Bhat V
    Psychiatry Res Neuroimaging; 2024 Mar; 338():111777. PubMed ID: 38183847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Limbic system white matter microstructure and long-term treatment outcome in major depressive disorder: a diffusion tensor imaging study using legacy data.
    Hoogenboom WS; Perlis RH; Smoller JW; Zeng-Treitler Q; Gainer VS; Murphy SN; Churchill SE; Kohane IS; Shenton ME; Iosifescu DV
    World J Biol Psychiatry; 2014 Feb; 15(2):122-34. PubMed ID: 22540406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pretreatment and early-treatment cortical thickness is associated with SSRI treatment response in major depressive disorder.
    Bartlett EA; DeLorenzo C; Sharma P; Yang J; Zhang M; Petkova E; Weissman M; McGrath PJ; Fava M; Ogden RT; Kurian BT; Malchow A; Cooper CM; Trombello JM; McInnis M; Adams P; Oquendo MA; Pizzagalli DA; Trivedi M; Parsey RV
    Neuropsychopharmacology; 2018 Oct; 43(11):2221-2230. PubMed ID: 29955151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resolution of sleepiness and fatigue in major depressive disorder: A comparison of bupropion and the selective serotonin reuptake inhibitors.
    Papakostas GI; Nutt DJ; Hallett LA; Tucker VL; Krishen A; Fava M
    Biol Psychiatry; 2006 Dec; 60(12):1350-5. PubMed ID: 16934768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accelerated Brain Aging in Adults With Major Depressive Disorder Predicts Poorer Outcome With Sertraline: Findings From the EMBARC Study.
    Jha MK; Chin Fatt C; Minhajuddin A; Mayes TL; Trivedi MH
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2023 Apr; 8(4):462-470. PubMed ID: 36179972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of anxiety symptoms in major depressive disorder: a meta-analysis of individual patient data from 10 double-blind, randomized clinical trials.
    Papakostas GI; Trivedi MH; Alpert JE; Seifert CA; Krishen A; Goodale EP; Tucker VL
    J Psychiatr Res; 2008 Jan; 42(2):134-40. PubMed ID: 17631898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tractography of the brainstem in major depressive disorder using diffusion tensor imaging.
    Song YJ; Korgaonkar MS; Armstrong LV; Eagles S; Williams LM; Grieve SM
    PLoS One; 2014; 9(1):e84825. PubMed ID: 24465436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroanatomical correlates of apathy in late-life depression and antidepressant treatment response.
    Yuen GS; Gunning FM; Woods E; Klimstra SA; Hoptman MJ; Alexopoulos GS
    J Affect Disord; 2014 Sep; 166():179-86. PubMed ID: 25012429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential antidepressant symptom efficacy: placebo-controlled comparisons of duloxetine and SSRIs (fluoxetine, paroxetine, escitalopram).
    Mallinckrodt CH; Prakash A; Houston JP; Swindle R; Detke MJ; Fava M
    Neuropsychobiology; 2007; 56(2-3):73-85. PubMed ID: 18037817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials.
    Wagner KD; Ambrosini P; Rynn M; Wohlberg C; Yang R; Greenbaum MS; Childress A; Donnelly C; Deas D;
    JAMA; 2003 Aug; 290(8):1033-41. PubMed ID: 12941675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A post hoc analysis of the effect of nightly administration of eszopiclone and a selective serotonin reuptake inhibitor in patients with insomnia and anxious depression.
    Fava M; Schaefer K; Huang H; Wilson A; Iosifescu DV; Mischoulon D; Wessel TC
    J Clin Psychiatry; 2011 Apr; 72(4):473-9. PubMed ID: 21208574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Sertraline on Depressive Symptoms in Patients With Chronic Kidney Disease Without Dialysis Dependence: The CAST Randomized Clinical Trial.
    Hedayati SS; Gregg LP; Carmody T; Jain N; Toups M; Rush AJ; Toto RD; Trivedi MH
    JAMA; 2017 Nov; 318(19):1876-1890. PubMed ID: 29101402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Intrinsic Patterns of Functional Brain Connectivity in Moderating Antidepressant Treatment Response in Major Depression.
    Chin Fatt CR; Jha MK; Cooper CM; Fonzo G; South C; Grannemann B; Carmody T; Greer TL; Kurian B; Fava M; McGrath PJ; Adams P; McInnis M; Parsey RV; Weissman M; Phillips ML; Etkin A; Trivedi MH
    Am J Psychiatry; 2020 Feb; 177(2):143-154. PubMed ID: 31537090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reward related ventral striatal activity and differential response to sertraline versus placebo in depressed individuals.
    Greenberg T; Fournier JC; Stiffler R; Chase HW; Almeida JR; Aslam H; Deckersbach T; Cooper C; Toups MS; Carmody T; Kurian B; Peltier S; Adams P; McInnis MG; Oquendo MA; Fava M; Parsey R; McGrath PJ; Weissman M; Trivedi M; Phillips ML
    Mol Psychiatry; 2020 Jul; 25(7):1526-1536. PubMed ID: 31462766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.